ラボオートメーション市場規模、シェア、動向、2031年までの世界予測

世界のラボオートメーション市場は、2026年の66億米ドルから2031年には86億2,000万米ドルに達するとMarketsandMarketsでは予測されており、年平均成長率（CAGR）は6.6%になると見込みです。

ラボオートメーション導入を促進する主な要因としては、ハイスループット検査の需要、オミクス研究の拡大、そして検査手順におけるより正確で迅速な結果へのニーズなどが挙げられます。さらに、慢性疾患の罹患率の上昇に伴い、研究開発への投資が増加し、より迅速な診断への需要が高まっていることも、ラボにおけるオートメーション導入をさらに加速させる要因となっています。

調査概要

本レポートは、製品、用途、エンドユーザー、地域別に市場を分類しています。また、ラボオートメーション市場に影響を与える様々な要因（推進要因、制約、機会、課題など）についても考察しています。ステークホルダーが直面する機会と課題に関する洞察を提供するとともに、主要企業の競争環境を分析しています。さらに、マイクロマーケットを細分化し、成長トレンド、将来展望、そしてこれらのトレンドがラボオートメーション市場にどのように貢献しているかを検証しています。5つの主要地域における成長に焦点を当て、様々な市場セグメントにおける収益予測も行っています。

本レポートを購入する主なメリット

本レポートは、ラボオートメーション市場における新規参入企業と既存企業の両方に役立つように設計されています。ステークホルダーが潜在的な投資機会を特定するのに役立つ詳細な情報を提供します。市場における主要企業とマイナー企業の両方に関する包括的な詳細情報が含まれており、効果的なリスク分析と情報に基づいた投資判断を支援します。エンドユーザーと地域による正確なセグメンテーションにより、特定の市場セグメントに関するニッチレベルの洞察を提供します。さらに、重要なトレンド、課題、成長推進要因、機会を明確に示し、包括的な戦略的意思決定プロセスに貢献します。

• 本レポートでは、読者の皆様に以下の項目に関する洞察を提供します。ラボオートメーション市場の成長に影響を与える主要な成長促進要因、阻害要因、課題、機会の分析。
• 製品開発／イノベーション：抗菌薬感受性試験市場における新興技術、進行中の研究開発活動、および最近の製品・サービスの発売状況。
• 市場動向：本レポートでは、ラボオートメーション市場を地域別に分析しています。
• 市場の多様化：ラボオートメーション市場における新製品の発売、未開拓市場、最近の動向、および投資状況。

Report Description

The global lab automation market is expected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, at a CAGR of 6.6%. Key factors driving the adoption of lab automation include the demand for high-throughput testing, the rise in omics research, and the need for more accurate and faster results in laboratory procedures. Additionally, the increasing prevalence of chronic diseases is driving greater investment in research and development and a demand for faster diagnoses, further accelerating the adoption of automation in laboratories.

“The automated workstations segment accounted for the largest market share in 2025.”

The automated workstations segment is expected to lead the lab automation market during the forecast period. This product line enhances laboratory workflow by offering streamlined workstations, increased precision, and improved reproducibility across various applications. Among automated workstation products, liquid-handling workstations are commonly used for high-accuracy sample and reagent transfer, which is essential for applications such as PCR, qPCR, and next-generation sequencing. Another significant subsegment is microplate readers, which enable high-throughput screening and assay quantification, thereby accelerating drug discovery and biological research. Additionally, automated ELISA systems are in high demand because they streamline the time-consuming protocols involved in immunoassays. These systems enable diagnostics and clinical laboratories to save considerable time by automating all immunoassay procedures, delivering rapid, reliable results while minimizing manual intervention. Moreover, automated nucleic acid purification systems are essential for molecular biology and genomics research, as they expedite DNA and RNA extraction and purification for subsequent applications. The growth in these subsegments reflects the lab automation market’s focus on increasing efficiency and data quality, which are crucial factors in pharmaceutical, diagnostic, and research settings.

“The hospitals & diagnostic laboratories segment held the largest share of the lab automation market in 2025.”

The lab automation market is segmented by end user: hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, environmental testing laboratories, forensic laboratories, and the food & beverage industry. By 2025, hospitals & diagnostic laboratories are expected to hold the largest market share. This growth is primarily driven by increasing demand for throughput, accuracy, and high-speed diagnostic solutions necessary to treat more patients who require a variety of complex tests. Automation solutions in these settings will help simplify workflows, reduce turnaround times, and enhance accuracy.

“Asia Pacific is expected to register the highest growth rate in the market during the forecast period.”

The Asia Pacific region is expected to lead the growth in the lab automation market, showing the highest growth rate during the forecast period. This growth will be fueled by increased investment in healthcare infrastructure, a strong emphasis on research and development from the pharmaceutical and biotechnology industries, and a rising demand for efficient diagnostic solutions to serve the region’s growing population. Additionally, advancements in artificial intelligence and robotics are helping laboratories in various sectors become more automated.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 (30%), Tier 2 (42%), and Tier 3 (28%)
• By Designation: C-level Executives (10%), Directors (15%), and Other Designations (75%)
• By Region: North America (40%), Europe (30%), Asia Pacific (22%), and the Rest of the World (8%)

Prominent players in the lab automation market include Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMérieux (France), Hamilton Company (US), and Hudson Robotics (US).

Research Coverage

The market is organized by product, application, end user, and region. The report also discusses various factors impacting the lab automation market, including drivers, constraints, opportunities, and challenges. It offers insights into the opportunities and challenges facing stakeholders and profiles the competitive landscape of leading players. Additionally, micromarkets are further divided by examining growth trends, prospects, and how these trends contribute to the lab automation market. Revenue generation across different market segments will be forecasted, with a focus on growth in five major geographic regions.

Key Benefits of Buying this Report

This report is designed to benefit both new and existing players in the lab automation market. It provides in-depth information that helps stakeholders identify potential investment opportunities. The report includes comprehensive details about both key and minor players in the market, supporting effective risk analysis and informed investment decisions. With accurate segmentation by end users and geographic regions, the report offers niche-level insights into specific market segments. Furthermore, it highlights critical trends, challenges, growth drivers, and opportunities, which contribute to a well-rounded strategic decision-making process.

• Through this report, readers get insightful views into the following parameters: Analysis of the key growth drivers, restraints, challenges, and opportunities influencing the market growth for the lab automation market.
• Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.
• Market Development: The report segments the lab automation market by region.
• Market Diversification: New product launches, unexploited markets, recent developments, and investments in the lab automation market.

Table of Contents

---

---